bioMerieux (FR:BIM) has released an update.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
bioMérieux, a prominent player in the biotech industry, has released its monthly report detailing 118,361,220 shares and a total of 191,139,182 theoretical voting rights as of September 30, 2024. This report aligns with regulatory compliance for voting rights and share numbers under French Commercial Code and Financial Markets Authority regulations.
For further insights into FR:BIM stock, check out TipRanks’ Stock Analysis page.